BPG is committed to discovery and dissemination of knowledge
About the Journal
Name of Journal Artificial Intelligence in Cancer
Title Abbreviation Artif Intell Cancer
ISSN 2644-3228 (online)
Launch Date June 28, 2020
Frequency Continuous Publication
DOI 10.35713
Background

Artificial Intelligence in Cancer (AIC, Artif Intell Cancer) is a high-quality, open-access academic journal that employs a single-blind peer-review process. The journal focuses on publishing innovative, novel, and practical clinical, basic, and translational research achievements in the fields of artificial intelligence in cancer. The types of articles published in AIC include Editorial, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. All submissions must comply with academic norms and ethical requirements. The journal is edited and published by the Baishideng Publishing Group.

Aim

The primary aim of AIC is to provide scholars and readers from various fields of artificial intelligence in cancer with a platform for publishing high-quality clinical, basic, and translational research achievements. In order to ensure the quality, fairness, and transparency of publication, AIC has implemented a variety of measures, as follows: 

1 Academic norms and ethical requirements. Adherence to both academic norms and ethical requirements is closely related to peer review and first-decision making for the manuscript. Authors are recommended to prepare their articles according to the appropriate international publication recommendations, including the STROBE Statement, CONSORT 2010 Statement, PRISMA 2009 Checklist, and CARE Checklist – 2016: Information for writing a case report. For all articles involving human studies, organ transplantations, and/or animal experiments, before their acceptance, author(s) must provide the related formal ethics documents that were reviewed and approved by their local ethical review committee. For full guidelines for authors, please visit: https://www.wjgnet.com/bpg/gerinfo/204.

2 Peer-review process. Articles published in AIC must undergo rigorous external, single-blind peer review. For the full peer-review process, please visit: https://www.wjgnet.com/bpg/gerinfo/241.

3 Designation of co-first authors and/or co-corresponding authors. Designation of co-first authors and/or co-corresponding authors is permitted. For the policy of allowing co-first authors and co-corresponding authors who made equal contribution to a manuscript, please visit: https://www.wjgnet.com/bpg/GerInfo/310.

4 Publication of innovative original articles. AIC's acceptance of a manuscript for publication is based on its novelty, innovativeness, data accuracy, image reliability, clear language expression, and ethical requirements. 

5 Disclosure of documents related to the article. The peer review report, author response to the peer review report, biostatistics review certificate, copyright license agreement, institutional ethics committee approval document, informed consent document(s), conflict-of-interest statement, CrossCheck detection report, corresponding author(s) personal ORCID number(s), funding information, language editing certificate, and other relevant documents will be published online along with the article to allow for an open and transparent publishing process. 

Scope AIC mainly publishes articles reporting research results obtained in the field of artificial intelligence in cancer and covering a wide range of topics, including artificial intelligence in bone oncology, breast cancer, gastrointestinal cancer, genitourinary cancer, gynecological cancer, head and neck cancer, hematologic malignancy, lung cancer, lymphoma and myeloma, pediatric oncology, and urologic oncology.
Open Access Open access
Indexing/Abstracting

The AIC is now abstracted and indexed in Reference Citation Analysis, China Science and Technology Journal Database.

Journal Metrics

There is currently no impact factor.

Article Processing Charge Article processing charge
Editors-in-Chief Cedric Coulouarn
Publisher Publisher
Research Domain
Article Reprints Article reprints
Permissions Permissions
Help Desk Help desk
Special Statement Special statement
About the BPG Baishideng Publishing Group (BPG), founded in 1993, is headquartered in California, USA. BPG is committed to editing and publishing high-quality, open-access, peer-reviewed clinical medical journals. Our team consists of administrative team, Editorial Office, and Production Department. Our mission is to provide high-quality platforms for authors to publish clinical, basic, and translational medical research results. Our vision is to help authors expand their academic influence, provide readers with high-quality academic content, and lead the development of the field. Our values are to adhere to our review guidelines, decision guidelines, and publication ethics, to ensure the fairness, openness, and transparency of the process from the author's submission to the first review, peer review, and final review, and to edit and publish each high-quality peer-reviewed article.
Copyright © © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Contact Us Contact us